Jacqueline Foster
Physician Assistant · Sarasota, FLNPI 1851529697
Payments from drug & device makers
Across 179 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$485
- GSK$428
- Pfizer$381
- Lilly USA, LLC$375
- Novo Nordisk$336
- Amgen$331
- plus $946 from 17 others
What the payments were for
- Food & beverage$3,281100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 19 | $485 |
| GSK | 27 | $428 |
| Pfizer | 28 | $381 |
| Lilly USA, LLC | 23 | $375 |
| Novo Nordisk | 18 | $336 |
| Amgen | 19 | $331 |
| Exact Sciences | 10 | $281 |
| AbbVie | 7 | $147 |
| Boehringer Ingelheim | 5 | $86 |
| Daiichi Sankyo Inc. | 3 | $64 |
| Merck | 3 | $61 |
| AstraZeneca | 4 | $58 |
| Boston Scientific | 1 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Abbott | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Nevro Corp. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
How this compares
$3,281 in reported general payments places this provider in the 80th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $15,880 |
| LinzessLinaclotide | 12 | $9,764 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $7,723 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 54 | $1,707 |
| Gabapentin | 21 | $739 |
| Atorvastatin Calcium | 76 | $595 |
| Levothyroxine Sodium | 62 | $483 |
| Lisinopril | 48 | $427 |
| Losartan Potassium | 39 | $411 |
| Buspirone Hcl | 18 | $405 |
| Pantoprazole Sodium | 27 | $360 |
| Metoprolol Tartrate | 25 | $341 |
| Cephalexin | 20 | $303 |
| Fluticasone Propionate | 15 | $292 |
| Omeprazole | 31 | $290 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $381 | $15,88011 claims |
| AbbVieLinzess | $147 | $9,76412 claims |
| GSKTrelegy Ellipta | $428 | $7,72312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Sarasota
- Daniel SellersSarasota$120K
- Sonja BaerSarasota$82K
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.